Both in Pharmaceuticals
Dianthus Therapeutics vs Veradermics, Incorporated
Over the past year DNTH returned +81.1% and MANE returned +212.1%; their daily moves had a correlation of 0.22.
DNTH +81.1% MANE +212.1%Growth of $1, one year, split-adjusted
| Metric | DNTH | MANE |
|---|---|---|
| Price | $87.16 | $117.82 |
| Market cap | $4.88B | $4.92B |
| Today | −0.76% | +2.45% |
| 1 month | −17.6% | +20.3% |
| 6 months | +9.7% | +93.6% |
| Year to date | +111.5% | — |
| 1 year | +137.4% | — |
| Revenue growth (YoY) | +294.3% | — |
| Gross margin | 100.0% | — |
| Net margin | −6598.6% | — |
| P/E (TTM) | — | — |
| Price / sales | 2,560.5× | — |
| Net cash | $886.8M | $819.9M |
| Dividend yield | — | — |
| Volatility (60d) | 49.0% | 66.0% |
| Short % of float | 17.2% | 17.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).